The size of the Europe Drug Screening Market is valued at USD 1.59 billion in 2020. It is expected to grow at a CAGR of 9.40% to approach USD 2.5 billion by 2025.
Rising drug abuse among the European countries, increasing alcohol consumption and illicit drugs, growing funds from the government to control drug marketing, rising awareness regarding the drug screening policy are majorly supporting and accelerating the drug screening market in Europe. An estimated 3.3 million people are dying due to the deadly effects of alcohol and almost half of the deaths are avoidable with developing, organizing, monitoring, and evaluation of treatment and other services. Growing competition and an increasing number of mergers and acquisitions between the market participants are expected to offer new growth possibilities in the near future.
Strict laws and ban on alcohol consumption in the European countries are expected to restrain the market to a limited extent during the forecast period. Drug screening is considered as an offense of privacy rights, accuracy issues with breathalyzers are restraining the market growth during the analysis period.
This research report on the Europe Drug Screening Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
The European market proved to be the second-highest market among all the regions in terms of the market share that contributed to the global market. This trend is predicted to be continued in the future as well, majorly because of the enactment of new and more stringent regulations by the governments of several countries in the region.
The drug screening market in the UK was accounted for the leading share in the European market due to the surging consciousness on the people’s health, new technology inventions that provide exact and correct results.
France and Germany are expected to have quick growth in the market. Development and obtaining of new procedures and methods along with devices towards drug screening are predicted to offer some crucial opportunities in the market, immense usage of drug screening activities particularly in railways, transport, and airline sector is expected to dominate the market growth.
Key players operating in the Europe Drug Screening Market profiled in this report are Thermo Fisher Scientific Inc., Express Diagnostics Int’l Inc., Abbott Laboratories, Siemens AG, Alere Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Biorad Laboratories Inc., Shimadzu and Omega Laboratories.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sample Type
5.1.1 Introduction
5.1.2 Hair
5.1.3 Blood
5.1.4 Urine
5.1.5 Others
5.1.6 Y-o-Y Growth Analysis, By Sample Type
5.1.7 Market Attractiveness Analysis, By Sample Type
5.1.8 Market Share Analysis, By Sample Type
5.2 End-user
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Workplaces
5.2.4 Criminal Justice & Law Enforcement
5.2.5 Y-o-Y Growth Analysis, By End-user
5.2.6 Market Attractiveness Analysis, By End-user
5.2.7 Market Share Analysis, By End-user
5.3 Products and Services
5.3.1 Introduction
5.3.2 Breathalyser
5.3.3 Rapid Test Device
5.3.4 Immunoassay Analyser
5.3.5 Chromatography
5.3.6 Other Products
5.3.7 Y-o-Y Growth Analysis, By Products and Services
5.3.8 Market Attractiveness Analysis, By Products and Services
5.3.9 Market Share Analysis, By Products and Services
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Sample Type
6.1.3.3 By End-user
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Sample Type
6.1.4.3 By End-user
6.1.4.4 By Products and Services
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Sample Type
6.1.5.3 By End-user
6.1.5.4 By Products and Services
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Express Diagnostics Int’l Inc.
8.3 Abbott Laboratories
8.4 Siemens AG
8.5 Alere Inc.
8.6 Quest Diagnostics Incorporated
8.7 Laboratory Corporation of America Holdings
8.8 Biorad Laboratories Inc.
8.9 Shimadzu
8.10 Omega Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
